Fierce Biotech January 19, 2024
Andrea Park

Dexcom has joined the scrum of major U.S.-based medtech companies flocking to Ireland as a European home base.

The glucose sensor maker has broken on a new manufacturing facility planned for the small town of Athenry in County Galway, it announced Friday, marking the company’s first manufacturing site in Europe.

According to Dexcom, placing an outpost in Western Ireland will open up a new channel for distributing its diabetes management devices throughout the continent, as well as the Middle East and Africa—potentially lowering costs and speeding up delivery times, which will also help to improve the company’s sustainability efforts.

When the Irish government’s Industrial Development Agency, known as IDA Ireland, announced last May Dexcom’s plans to break ground in the...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Medical Devices
Qualcomm CEO: AI Is the New User Interface for Devices
FTC sues to block merger of device coatings companies
Boston Scientific to acquire SoniVie for $540 million, expand hypertension treatment portfolio
Medicare Coverage Of Medical Technologies In A New Era
This year's top congressional medical technology priorities

Share This Article